JP2016531868A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531868A5
JP2016531868A5 JP2016517332A JP2016517332A JP2016531868A5 JP 2016531868 A5 JP2016531868 A5 JP 2016531868A5 JP 2016517332 A JP2016517332 A JP 2016517332A JP 2016517332 A JP2016517332 A JP 2016517332A JP 2016531868 A5 JP2016531868 A5 JP 2016531868A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
hydrogen atom
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016517332A
Other languages
English (en)
Japanese (ja)
Other versions
JP6402179B2 (ja
JP2016531868A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/070484 external-priority patent/WO2015044267A1/en
Publication of JP2016531868A publication Critical patent/JP2016531868A/ja
Publication of JP2016531868A5 publication Critical patent/JP2016531868A5/ja
Application granted granted Critical
Publication of JP6402179B2 publication Critical patent/JP6402179B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016517332A 2013-09-26 2014-09-25 新規な、NIK阻害剤としての1−(4−ピリミジニル)−1H−ピロロ[3,2−c]ピリジン誘導体 Expired - Fee Related JP6402179B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13186139.5 2013-09-26
EP13186139 2013-09-26
EP14176121 2014-07-08
EP14176121.3 2014-07-08
PCT/EP2014/070484 WO2015044267A1 (en) 2013-09-26 2014-09-25 NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS

Publications (3)

Publication Number Publication Date
JP2016531868A JP2016531868A (ja) 2016-10-13
JP2016531868A5 true JP2016531868A5 (enExample) 2017-11-02
JP6402179B2 JP6402179B2 (ja) 2018-10-10

Family

ID=51619194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016517332A Expired - Fee Related JP6402179B2 (ja) 2013-09-26 2014-09-25 新規な、NIK阻害剤としての1−(4−ピリミジニル)−1H−ピロロ[3,2−c]ピリジン誘導体

Country Status (14)

Country Link
US (1) US10005773B2 (enExample)
EP (1) EP3071566B1 (enExample)
JP (1) JP6402179B2 (enExample)
KR (1) KR102317334B1 (enExample)
CN (1) CN105579451B (enExample)
AU (1) AU2014327233B2 (enExample)
BR (1) BR112016005914A2 (enExample)
CA (1) CA2922753C (enExample)
EA (1) EA029595B1 (enExample)
ES (1) ES2804595T3 (enExample)
IL (1) IL244706B (enExample)
MX (1) MX373186B (enExample)
TW (1) TWI704146B (enExample)
WO (1) WO2015044267A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
US9981962B2 (en) 2014-10-23 2018-05-29 Janssen Pharmaceutica Nv Pyrazole derivatives as NIK inhibitors
MX371153B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv Nuevos compuestos como inhibidores de la cinasa inductora de nf-kb (nik).
AU2015334914B2 (en) 2014-10-23 2019-09-19 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as NIK inhibitors
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体
WO2017125530A1 (en) 2016-01-22 2017-07-27 Janssen Pharmaceutica Nv New substituted cyanoindoline derivatives as nik inhibitors
CN109311846B (zh) * 2016-01-22 2021-03-19 杨森制药有限公司 作为nik抑制剂的新的6元杂芳族取代的氰基吲哚衍生物
CN109641882B (zh) * 2016-06-30 2022-10-28 杨森制药有限公司 作为nik抑制剂的杂芳族衍生物
WO2018002219A1 (en) 2016-06-30 2018-01-04 Janssen Pharmaceutica Nv Cyanoindoline derivatives as nik inhibitors
JP7138093B2 (ja) * 2016-08-24 2022-09-15 エフ.ホフマン-ラ ロシュ アーゲー 2-アザビシクロ[3.1.0]ヘキサン-3-オン誘導体及び使用方法
JP7140751B2 (ja) 2016-08-24 2022-09-21 エフ.ホフマン-ラ ロシュ アーゲー 2-アザビシクロ[3.1.0]ヘキサン-3-オン誘導体及び使用方法
FI3976597T3 (fi) 2019-05-31 2024-09-25 Janssen Pharmaceutica Nv Nf-kb:tä indusoivan kinaasin pienimolekyylisiä estäjiä
CN113816957B (zh) * 2021-10-29 2023-04-07 浙江工业大学 4-(7-氮杂吲哚)-2-氨基嘧啶类化合物及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3990061B2 (ja) * 1998-01-05 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 プリン誘導体および糖尿病の予防・治療剤としてのアデノシンa2受容体拮抗剤
WO2005103003A2 (en) 2004-04-26 2005-11-03 Pfizer Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
TW200736260A (en) * 2005-11-10 2007-10-01 Smithkline Beecham Corp Inhibitors of Akt activity
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
US20110086834A1 (en) 2008-06-26 2011-04-14 Amgen Inc. Alkynyl alcohols as kinase inhibitors
JP2011526931A (ja) * 2008-07-03 2011-10-20 エグゼリクシス, インコーポレイテッド Cdkモジュレーター
US20110183975A1 (en) * 2008-10-07 2011-07-28 Yasuhiro Goto Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2011050245A1 (en) * 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CN103476768B (zh) * 2011-03-16 2015-07-08 弗·哈夫曼-拉罗切有限公司 6,5-杂环炔丙醇化合物及其用途
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) * 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
AU2015334914B2 (en) 2014-10-23 2019-09-19 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as NIK inhibitors
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体
MX371153B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv Nuevos compuestos como inhibidores de la cinasa inductora de nf-kb (nik).
US9981962B2 (en) 2014-10-23 2018-05-29 Janssen Pharmaceutica Nv Pyrazole derivatives as NIK inhibitors

Similar Documents

Publication Publication Date Title
JP2016531868A5 (enExample)
JP2016531858A5 (enExample)
JP2017531677A5 (enExample)
JP2014518286A5 (enExample)
JP2015535277A5 (enExample)
JP2016506369A5 (enExample)
JP2013528204A5 (enExample)
WO2016105528A3 (en) Inhibitors of cyclin-dependent kinase 7 (cdk7)
JP2017509689A5 (enExample)
JP2017531678A5 (enExample)
JP2016516043A5 (enExample)
JP2016537369A5 (enExample)
JP2016532715A5 (enExample)
JP2014523857A5 (enExample)
JP2016530262A5 (enExample)
JP2016537366A5 (enExample)
JP2013533883A5 (enExample)
JP2016540742A5 (enExample)
JP2015514806A5 (enExample)
JP2015531773A5 (enExample)
JP2015520140A5 (enExample)
JP2017514910A5 (enExample)
JP2014509647A5 (enExample)
JP2016507581A5 (enExample)
JP2013502441A5 (enExample)